Medad Technology Parent: Medad Holding

Medad Technology has developed an ultrasonic delivery system that revolutionizes inhalation technology and overcomes the limitations of traditional aerosol delivery, offering applications in both consumer and pharmaceutical HealthTech sectors. The core technology works under the Resonant Drive System (RDS) method. This incorporates a natural frequency-finding electronics system for which a complete set of proprietary ASICs and an algorithm has been developed. The algorithm works with the electronics to form a feedback loop that looks for the resonant point at the start of each inhalation for optimal aerosol delivery efficiency. The closed system consists of a Bluetooth-enabled device, disposable pod, and mobile app to monitor usage data, such as the number of inhalations and pod consumption levels. The system 3 key product applications that provide cutting-edge solutions to tackle tobacco dependence and improve drug delivery, with design scalability to meet diverse market needs. In addition to its headquarters in the UAE, the company has operations in the US and the UK.